Capacity Bio
PrivateLast Round
Series A
Mar 31, 2023
Total Funding Raised
$35M
Company Overview
Capacity Bio is a biotechnology company developing a first-in-class mitophagy therapeutic platform and advanced analytical tools to restore mitochondrial quality control for the treatment of neurodegenerative, autoimmune, and muscular disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Capacity Bio Comparables
Compare Capacity Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vandria | 85% | |
| MitoRx Therapeutics | 81% | |
| Mitochon Pharmaceuticals | 79% |
Capacity Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 31, 2023 |
Capacity Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Seed, Series A |
| Remiges Ventures | Series A, Seed |
| Insight Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2023
$35M round led by Insight Partners and RA Capital Management.
Capacity Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Capacity Bio's valuation, stock price, and market status.
Is Capacity Bio a public or private company?
Capacity Bio is a private company.
What is the current stock price of Capacity Bio?
Capacity Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Capacity Bio worth (valuation)?
Valuation information for Capacity Bio is not publicly available.
Can I buy Capacity Bio stock?
Capacity Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Capacity Bio's last funding round?
Capacity Bio's most recent funding round was VC Round on March 31, 2023.
Who are the main investors in Capacity Bio?
Key investors in Capacity Bio include RA Capital Management, Insight Partners.
Will Capacity Bio IPO soon?
No public IPO plans have been announced for Capacity Bio.
How can I track Capacity Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Capacity Bio's secondary market activity and sign up for updates.